During the early phase of VC, exogenous TGF-β1 without OM did not increase AR positive nodules relative to the control group, while TGF-β1 cotreated with OM led to significantly more AR positive nodules, followed by the OM only group (Figure 2A, 2B). Here, TGFB1 is linked to ocular melanoma.